Work

S1308 Treatment Outcomes of Prolonged Induction or Re-Escalation Dosing of Upadacitinib in Patients With Inflammatory Bowel Disease

Year: 2024

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001034600.37922.a6

Authors: Ellen Axenfeld, Vasantham Annadurai, Joseph Clinton, Michael Frohlinger, Lauren George, Adam S. Faye, Raymond K. Cross, Jordan Axelrad

Institutions: NYU Langone Health, New York University, University of Maryland Medical Center, University of Maryland, Baltimore, Mercy Medical Center, Mercy Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403725168

Cites:

Cited by: 3

Related to: 10